PRSN Insider Trading Activity and SEC Form 4 Filings
PRSN insider trading summary
No open-market insider purchases or sales of Perseon Corp (PRSN) have been reported on SEC Form 4 in the past 12 months.
Latest PRSN insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 4, 2015 | Steven G Stewart | Director | Buy | $4K (5,000 @ $0.88) |
| Aug 4, 2015 | Timothy C McQuay | Director | Buy | $11K (12,000 @ $0.88) |
| Aug 4, 2015 | Clint Carnell | CEO | Buy | $26K (29,000 @ $0.88) |
| Aug 4, 2015 | Peter Vitulli | Director | Buy | $51K (58,000 @ $0.88) |
| Aug 4, 2015 | Todd Turnlund | VP Engineering | Buy | $44K (50,000 @ $0.88) |
| Aug 4, 2015 | Brian A. Meltzer | Chief Medical Officer | Buy | $880 (1,000 @ $0.88) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.